The math on employer-sponsored healthcare has reached an inflection point that demands strategic response. Healthcare expenditure for large employers is projected to increase 8.2% in 2026, the highest rate in over a decade, bringing average per-employee costs above $16,000 annually. For many companies, healthcare now represents the second or third largest expense category after payroll itself. CFOs and human resources leaders are responding with benefit designs that would have seemed radical just a few years ago—direct contracting with providers, centers of excellence programs, captive insurance structures, and aggressive pharmacy benefit management overhauls.
Direct contracting represents one of the most significant departures from traditional benefit administration. Under this model, employers negotiate directly with health systems, bypassing insurers for some or all medical services. Walmart pioneered this approach with its centers of excellence program for complex surgeries, flying employees to designated high-quality providers rather than using local facilities with variable outcomes. The company reported both better clinical results and lower total costs. Other large employers have followed, particularly for specialty pharmaceuticals and high-cost procedures where price variation across providers can exceed 300%.
Self-insurance has expanded well beyond its historical base among Fortune 500 companies. Mid-sized employers, aided by stop-loss insurance that caps catastrophic exposure, are increasingly assuming direct responsibility for employee healthcare costs rather than paying fixed premiums to insurers. This shift provides greater visibility into actual spending patterns, enables customized plan design, and retains underwriting gains that would otherwise accrue to carriers. The administrative complexity is substantial, however, requiring either significant internal capability or sophisticated third-party administration.
Pharmacy benefit management has emerged as a particular focus. The pharmaceutical supply chain involves opaque transactions between manufacturers, wholesalers, PBMs, and pharmacies, with rebates and discounts that frequently don't flow through to plan sponsors. Progressive employers are demanding greater transparency, shifting to pass-through pricing models where PBM compensation is decoupled from drug prices, and establishing formularies that aggressively favor generics and biosimilars when clinically appropriate. Some employers have launched their own pharmacies or contracted with disruptors like Mark Cuban's Cost Plus Drugs to bypass traditional channels entirely.
Mental health benefits have expanded dramatically in response to both employee demand and recognition of downstream cost impacts. The pandemic-era surge in anxiety, depression, and substance use disorders forced employers to acknowledge that mental health services previously treated as supplementary are actually essential. Virtual therapy platforms have proliferated, providing accessible and often lower-cost alternatives to traditional in-person sessions. Employee assistance programs have evolved from call centers offering referrals into comprehensive digital platforms with clinical integration. Employers that previously capped mental health visits have largely eliminated these restrictions.
Weight management and GLP-1 medications present a particularly acute dilemma. Drugs like Ozempic, Wegovy, and Mounjaro show dramatic efficacy for weight loss, with potential downstream benefits for diabetes, cardiovascular disease, and musculoskeletal conditions. However, annual costs exceeding $15,000 per patient, combined with uncertain long-term utilization patterns, have made these medications a line item that can materially affect overall plan costs. Employers are implementing various approaches: prior authorization requirements, coverage conditional on participation in lifestyle programs, or exclusions entirely. The policy choices made today may have significant implications for workforce health decades hence.
The competitive dynamics of healthcare benefits are intensifying. In tight labor markets, comprehensive health coverage serves as a retention and recruitment tool, particularly for employees with chronic conditions or family members requiring significant care. Employers must balance cost management against the risk of benefit structures that drive away talent. The most sophisticated organizations are using data analytics to understand which benefit design elements actually drive employee satisfaction and health outcomes, investing resources where returns are measurable while reducing spending on services that provide limited value. Healthcare strategy, once largely delegated to HR and insurance brokers, has become a C-suite imperative.